SOTTOTETTI, FEDERICO
SOTTOTETTI, FEDERICO
Acute thrombocytopenia: An unusual complication occurring after drug-eluting microspheres transcatheter hepatic chemoembolization
2011-01-01 Poggi, G.; Quaretti, P.; Montagna, B.; Sottotetti, F.; Tagliaferri, B.; Pozzi, E.; Amatu, A.; Pagella, C.; Bernardo, G.
Advanced salivary gland carcinoma expressing androgen receptor and HER2: targeted therapies first?
2020-01-01 Quaquarini, E.; Sottotetti, F.; Presti, D.
Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study
2022-01-01 Quaquarini, Erica; Sottotetti, Federico; Agustoni, Francesco; Pozzi, Emma; Malovini, Alberto; Teragni, Cristina Maria; Palumbo, Raffaella; Saltalamacchia, Giuseppe; Tagliaferri, Barbara; Balletti, Emanuela; Rinaldi, Pietro; Canino, Costanza; Pedrazzoli, Paolo; Bernardo, Antonio
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study
2020-01-01 Blondeaux, E.; Ferreira, A. R.; Poggio, F.; Puglisi, F.; Bighin, C.; Sottotetti, F.; Montemurro, F.; Poletto, E.; Lai, A.; Sini, V.; Minuti, G.; Mura, S.; Fontana, A.; Fregatti, P.; Cardinali, B.; Lambertini, M.; Del Mastro, L.
Cluster familiare di mesotelioma da esposizione residenziale
2023-01-01 Madeo, Domenico; Sellaro, Francesca; Paulin, Noemi; Oddone, Enrico; Sottotetti, Federico; Scafa, Fabrizio; Candura, Stefano M.
Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver.
2010-01-01 Poggi, G; Pozzi, E; Riccardi, Alberto; Tonini, S; Montagna, B; Quaretti, P; Tagliaferri, B; Sottotetti, F; Baiardi, P; Pagella, C; Minoia, C; Bernardo, G.
Eribulin across multiple lines of chemotherapy: A retrospective study on quality of life and efficacy in metastatic breast cancer patients
2017-01-01 Quaquarini, E.; Sottotetti, F.; D'Ambrosio, D.; Malovini, A.; Morganti, S.; Marinello, A.; Pavesi, L.; Frascaroli, M.
Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience
2022-01-01 Falanga, Francesco; Rinaldi, Pietro; Primiceri, Cristiano; Bortolotto, Chandra; Oneta, Olga; Agustoni, Francesco; Morbini, Patrizia; Saracino, Laura; Eleftheriou, Dimitrios; Sottotetti, Federico; Stella, Giulia Maria
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer
2018-01-01 Martel, S.; Poletto, E.; Ferreira, A. R.; Lambertini, M.; Sottotetti, F.; Bertolini, I.; Montemurro, F.; Bernardo, A.; Risi, E.; Zanardi, E.; Ziliani, S.; Mura, S.; Dellepiane, C.; Del Mastro, L.; Minisini, A. M.; Puglisi, F.
Impact of COVID-19 outbreak on cancer patient care and treatment: Data from an outpatient oncology clinic in Lombardy (Italy)
2020-01-01 Quaquarini, E.; Saltalamacchia, G.; Presti, D.; Caldana, G.; Tibollo, V.; Malovini, A.; Palumbo, R.; Teragni, C. M.; Balletti, E.; Mollica, L.; Biscaldi, E.; Frascaroli, M.; Bernardo, A.; Sottotetti, F.
Intravenous or oral vinorelbine plus capecitabine as first - line treatment in HER2- metastatic breast cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials.
2012-01-01 Strada, M. R.; Palumbo, R.; Bernardo, A.; Riccardi, Alberto; Teragni, C.; Poggi, G.; Frascaroli, M.; Amatu, A.; Montagna, B.; Sottotetti, F.; Tagliaferri, B.; Bernardo, G.
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials.
2012-01-01 Strada, Mr; Palumbo, R; Bernardo, A; Riccardi, Alberto; Teragni, C; Poggi, G; Frascaroli, M; Amatu, A; Montagna, B; Sottotetti, F; Tagliaferri, B; Bernardo, G.
Italian real life experience with ibrutinib: Results of a large observational study on 77 relapsed/refractory mantle cell lymphoma
2018-01-01 Broccoli, A.; Casadei, B.; Morigi, A.; Sottotetti, F.; Gotti, M.; Spina, M.; Volpetti, S.; Ferrero, S.; Spina, F.; Pisani, F.; Merli, M.; Visco, C.; Paolini, R.; Zilioli, V. R.; Baldini, L.; Di Renzo, N.; Tosi, P.; Cascavilla, N.; Molica, S.; Ilariucci, F.; Rigolin, G. M.; D'Alo, F.; Vanazzi, A.; Santambrogio, E.; Marasca, R.; Mastrullo, L.; Castellino, C.; Desabbata, G.; Scortechini, I.; Trentin, L.; Morello, L.; Argnani, L.; Zinzani, P. L.
Mental health and risk perception among Italian healthcare workers during the second month of the Covid-19 pandemic
2020-01-01 Gorini, A.; Fiabane, E.; Sommaruga, M.; Barbieri, S.; Sottotetti, F.; La Rovere, M. T.; Tremoli, E.; Gabanelli, P.
Nanoparticle albumin-bound paclitaxel (Nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: Prospective evaluation of activity, safety, and quality of life
2015-01-01 Palumbo, R.; Sottotetti, F.; Trifiro, G.; Piazza, E.; Ferzi, A.; Gambaro, A.; Spinapolice, E. G.; Pozzi, E.; Tagliaferri, B.; Teragni, C.; Bernardo, A.
OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma.
2009-01-01 Poggi, G; Amatu, A; Montagna, B; Quaretti, P; Minoia, C; Sottani, C; Villani, L; Tagliaferri, B; Sottotetti, F; Rossi, O; Pozzi, E; Zappoli, F; Riccardi, Alberto; Bernardo, G.
Palbociclib in metastatic breast cancer: Current evidence and real-life data
2019-01-01 Serra, F.; Lapidari, P.; Quaquarini, E.; Tagliaferri, B.; Sottotetti, F.; Palumbo, R.
Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study
2017-01-01 Lambertini, M.; Ferreira, A. R.; Di Meglio, A.; Poggio, F.; Puglisi, F.; Sottotetti, F.; Montemurro, F.; Poletto, E.; Bernardo, A.; Risi, E.; Dellepiane, C.; Sini, V.; Minuti, G.; Grasso, D.; Fancelli, S.; Del Mastro, L.
Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study
2021-01-01 Palumbo, R.; Torrisi, R.; Sottotetti, F.; Presti, D.; Rita Gambaro, A.; Collova, E.; Ferzi, A.; Agostinetto, E.; Maria Teragni, C.; Saltalamacchia, G.; Tagliaferri, B.; Balletti, E.; Bernardo, A.; Quaquarini, E.
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience
2019-01-01 Palumbo, R.; Sottotetti, F.; Quaquarini, E.; Gambaro, A.; Ferzi, A.; Tagliaferri, B.; Teragni, C.; Licata, L.; Serra, F.; Lapidari, P.; Bernardo, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Acute thrombocytopenia: An unusual complication occurring after drug-eluting microspheres transcatheter hepatic chemoembolization | 1-gen-2011 | Poggi, G.; Quaretti, P.; Montagna, B.; Sottotetti, F.; Tagliaferri, B.; Pozzi, E.; Amatu, A.; Pagella, C.; Bernardo, G. | |
| Advanced salivary gland carcinoma expressing androgen receptor and HER2: targeted therapies first? | 1-gen-2020 | Quaquarini, E.; Sottotetti, F.; Presti, D. | |
| Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study | 1-gen-2022 | Quaquarini, Erica; Sottotetti, Federico; Agustoni, Francesco; Pozzi, Emma; Malovini, Alberto; Teragni, Cristina Maria; Palumbo, Raffaella; Saltalamacchia, Giuseppe; Tagliaferri, Barbara; Balletti, Emanuela; Rinaldi, Pietro; Canino, Costanza; Pedrazzoli, Paolo; Bernardo, Antonio | |
| Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study | 1-gen-2020 | Blondeaux, E.; Ferreira, A. R.; Poggio, F.; Puglisi, F.; Bighin, C.; Sottotetti, F.; Montemurro, F.; Poletto, E.; Lai, A.; Sini, V.; Minuti, G.; Mura, S.; Fontana, A.; Fregatti, P.; Cardinali, B.; Lambertini, M.; Del Mastro, L. | |
| Cluster familiare di mesotelioma da esposizione residenziale | 1-gen-2023 | Madeo, Domenico; Sellaro, Francesca; Paulin, Noemi; Oddone, Enrico; Sottotetti, Federico; Scafa, Fabrizio; Candura, Stefano M. | |
| Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. | 1-gen-2010 | Poggi, G; Pozzi, E; Riccardi, Alberto; Tonini, S; Montagna, B; Quaretti, P; Tagliaferri, B; Sottotetti, F; Baiardi, P; Pagella, C; Minoia, C; Bernardo, G. | |
| Eribulin across multiple lines of chemotherapy: A retrospective study on quality of life and efficacy in metastatic breast cancer patients | 1-gen-2017 | Quaquarini, E.; Sottotetti, F.; D'Ambrosio, D.; Malovini, A.; Morganti, S.; Marinello, A.; Pavesi, L.; Frascaroli, M. | |
| Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience | 1-gen-2022 | Falanga, Francesco; Rinaldi, Pietro; Primiceri, Cristiano; Bortolotto, Chandra; Oneta, Olga; Agustoni, Francesco; Morbini, Patrizia; Saracino, Laura; Eleftheriou, Dimitrios; Sottotetti, Federico; Stella, Giulia Maria | |
| Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer | 1-gen-2018 | Martel, S.; Poletto, E.; Ferreira, A. R.; Lambertini, M.; Sottotetti, F.; Bertolini, I.; Montemurro, F.; Bernardo, A.; Risi, E.; Zanardi, E.; Ziliani, S.; Mura, S.; Dellepiane, C.; Del Mastro, L.; Minisini, A. M.; Puglisi, F. | |
| Impact of COVID-19 outbreak on cancer patient care and treatment: Data from an outpatient oncology clinic in Lombardy (Italy) | 1-gen-2020 | Quaquarini, E.; Saltalamacchia, G.; Presti, D.; Caldana, G.; Tibollo, V.; Malovini, A.; Palumbo, R.; Teragni, C. M.; Balletti, E.; Mollica, L.; Biscaldi, E.; Frascaroli, M.; Bernardo, A.; Sottotetti, F. | |
| Intravenous or oral vinorelbine plus capecitabine as first - line treatment in HER2- metastatic breast cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials. | 1-gen-2012 | Strada, M. R.; Palumbo, R.; Bernardo, A.; Riccardi, Alberto; Teragni, C.; Poggi, G.; Frascaroli, M.; Amatu, A.; Montagna, B.; Sottotetti, F.; Tagliaferri, B.; Bernardo, G. | |
| Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials. | 1-gen-2012 | Strada, Mr; Palumbo, R; Bernardo, A; Riccardi, Alberto; Teragni, C; Poggi, G; Frascaroli, M; Amatu, A; Montagna, B; Sottotetti, F; Tagliaferri, B; Bernardo, G. | |
| Italian real life experience with ibrutinib: Results of a large observational study on 77 relapsed/refractory mantle cell lymphoma | 1-gen-2018 | Broccoli, A.; Casadei, B.; Morigi, A.; Sottotetti, F.; Gotti, M.; Spina, M.; Volpetti, S.; Ferrero, S.; Spina, F.; Pisani, F.; Merli, M.; Visco, C.; Paolini, R.; Zilioli, V. R.; Baldini, L.; Di Renzo, N.; Tosi, P.; Cascavilla, N.; Molica, S.; Ilariucci, F.; Rigolin, G. M.; D'Alo, F.; Vanazzi, A.; Santambrogio, E.; Marasca, R.; Mastrullo, L.; Castellino, C.; Desabbata, G.; Scortechini, I.; Trentin, L.; Morello, L.; Argnani, L.; Zinzani, P. L. | |
| Mental health and risk perception among Italian healthcare workers during the second month of the Covid-19 pandemic | 1-gen-2020 | Gorini, A.; Fiabane, E.; Sommaruga, M.; Barbieri, S.; Sottotetti, F.; La Rovere, M. T.; Tremoli, E.; Gabanelli, P. | |
| Nanoparticle albumin-bound paclitaxel (Nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: Prospective evaluation of activity, safety, and quality of life | 1-gen-2015 | Palumbo, R.; Sottotetti, F.; Trifiro, G.; Piazza, E.; Ferzi, A.; Gambaro, A.; Spinapolice, E. G.; Pozzi, E.; Tagliaferri, B.; Teragni, C.; Bernardo, A. | |
| OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. | 1-gen-2009 | Poggi, G; Amatu, A; Montagna, B; Quaretti, P; Minoia, C; Sottani, C; Villani, L; Tagliaferri, B; Sottotetti, F; Rossi, O; Pozzi, E; Zappoli, F; Riccardi, Alberto; Bernardo, G. | |
| Palbociclib in metastatic breast cancer: Current evidence and real-life data | 1-gen-2019 | Serra, F.; Lapidari, P.; Quaquarini, E.; Tagliaferri, B.; Sottotetti, F.; Palumbo, R. | |
| Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study | 1-gen-2017 | Lambertini, M.; Ferreira, A. R.; Di Meglio, A.; Poggio, F.; Puglisi, F.; Sottotetti, F.; Montemurro, F.; Poletto, E.; Bernardo, A.; Risi, E.; Dellepiane, C.; Sini, V.; Minuti, G.; Grasso, D.; Fancelli, S.; Del Mastro, L. | |
| Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study | 1-gen-2021 | Palumbo, R.; Torrisi, R.; Sottotetti, F.; Presti, D.; Rita Gambaro, A.; Collova, E.; Ferzi, A.; Agostinetto, E.; Maria Teragni, C.; Saltalamacchia, G.; Tagliaferri, B.; Balletti, E.; Bernardo, A.; Quaquarini, E. | |
| Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience | 1-gen-2019 | Palumbo, R.; Sottotetti, F.; Quaquarini, E.; Gambaro, A.; Ferzi, A.; Tagliaferri, B.; Teragni, C.; Licata, L.; Serra, F.; Lapidari, P.; Bernardo, A. |